Sunshine Act Meetings, 92976-92977 [2024-27623]

Download as PDF 92976 Federal Register / Vol. 89, No. 227 / Monday, November 25, 2024 / Notices the requestor is a lineal descendant or a culturally affiliated Indian Tribe or Native Hawaiian organization. Repatriation of the cultural items in this notice to a requestor may occur on or after December 26, 2024. If competing requests for repatriation are received, the Museum of Us must determine the most appropriate requestor prior to repatriation. Requests for joint repatriation of the cultural items are considered a single request and not competing requests. The Museum of Us is responsible for sending a copy of this notice to the Indian Tribes and Native Hawaiian organizations identified in this notice and to any other consulting parties. Authority: Native American Graves Protection and Repatriation Act, 25 U.S.C. 3004 and the implementing regulations, 43 CFR 10.9. Dated: November 18, 2024. Melanie O’Brien, Manager, National NAGPRA Program. [FR Doc. 2024–27514 Filed 11–22–24; 8:45 am] BILLING CODE 4312–52–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–1411] Certain Photodynamic Therapy Systems, Components Thereof, and Pharmaceutical Products Used in Combination With the Same; Notice of Commission Determination Not To Review an Initial Determination Granting in Part Complainant’s Motion To Amend the Complaint and Notice of Investigation U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that the U.S. International Trade Commission has determined not to review an initial determination (‘‘ID’’) (Order No. 8) of the presiding administrative law judge (‘‘ALJ’’) issued in the above-captioned investigation, granting in part complainant’s motion to amend the complaint and notice of investigation (‘‘NOI’’) to add infringement allegations as to claims 17 and 18 of U.S. Patent No. 11,446,512 (‘‘the ’512 patent’’). FOR FURTHER INFORMATION CONTACT: Richard P. Hadorn, Esq., Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205–3179. Copies of non-confidential documents filed in connection with this investigation may be viewed on the khammond on DSK9W7S144PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:29 Nov 22, 2024 Jkt 265001 Commission’s electronic docket (EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email EDIS3Help@usitc.gov. General information concerning the Commission may also be obtained by accessing its internet server at https://www.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal, telephone (202) 205–1810. SUPPLEMENTARY INFORMATION: The Commission instituted this investigation on August 1, 2024, based on a complaint filed by Sun Pharmaceutical Industries, Inc. (‘‘Sun Pharma’’) of Princeton, New Jersey. 89 FR 62790 (Aug. 1, 2024). The complaint, as supplemented, alleges violations of section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, based on the importation into the United States, the sale for importation, and the sale within the United States after importation of certain photodynamic therapy systems, components thereof, and pharmaceutical products used in combination with the same by reason of infringement of certain claims of the ’512 patent and U.S. Patent No. 11,697,028 (‘‘the ’028 patent’’). Id. The complaint further alleges that a domestic industry exists or is in the process of being established. Id. The notice of investigation names four respondents: (1) Biofrontera Inc. of Woburn, Massachusetts; (2) Biofrontera Pharma GmbH of Leverkusen, Germany; (3) Biofrontera Bioscience GmbH of Leverkusen, Germany; and (4) Biofrontera AG of Leverkusen, Germany (collectively, ‘‘Biofrontera’’). Id. The Office of Unfair Import Investigations is not a party to this investigation. Id. On October 7, 2024, Sun Pharma filed a motion to amend the complaint and NOI to add infringement allegations as to claims 9, 11, 17, and 18 of the ’512 patent and claims 10 and 12 of the ’028 patent. On October 17, 2024, Biofrontera filed a response opposing-in-part the motion. Specifically, Biofrontera did not oppose the motion with respect to adding infringement allegations as to claims 17 and 18 of the ’512 patent, but opposed the remainder of the motion. On October 22, 2024, the ALJ issued the subject ID granting the motion in part. The ID finds that, in accordance with Commission Rule 210.14(b) (19 CFR 210.14(b)), good cause exists for amending the complaint and NOI to add infringement allegations as to claims 17 and 18 of the ’512 patent, noting that ‘‘Biofrontera agrees that Sun Pharma’s allegations with respect to these claims are based on information obtained PO 00000 Frm 00093 Fmt 4703 Sfmt 4703 through discovery.’’ ID at 3. The ALJ, however, found that Sun Pharma has not shown the requisite good cause to amend the complaint and NOI to add infringement allegations as to claims 9 and 11 of the ’512 patent and claims 10 and 12 of the ’028 patent because ‘‘Sun Pharma failed to demonstrate why it was unable to bring the allegations [of those claims] in the complaint.’’ Id. at 3–5. No petitions for review of the subject ID were filed. The Commission has determined not to review the subject ID. The complaint and NOI are amended to add infringement allegations as to claims 17 and 18 of the ’512 patent. The Commission vote for this determination took place on November 20, 2024. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). By order of the Commission. Issued: November 20, 2024. Lisa Barton, Secretary to the Commission. [FR Doc. 2024–27568 Filed 11–22–24; 8:45 am] BILLING CODE 7020–02–P NUCLEAR REGULATORY COMMISSION [NRC–2024–0001] Sunshine Act Meetings Weeks of November 25 and December 2, 9, 16, 23, 30, 2024. The schedule for Commission meetings is subject to change on short notice. The NRC Commission Meeting Schedule can be found on the internet at: https:// www.nrc.gov/public-involve/publicmeetings/schedule.html. PLACE: The NRC provides reasonable accommodation to individuals with disabilities where appropriate. If you need a reasonable accommodation to participate in these public meetings or need this meeting notice or the transcript or other information from the public meetings in another format (e.g., braille, large print), please notify Anne Silk, NRC Disability Program Specialist, at 301–287–0745, by videophone at 240–428–3217, or by email at Anne.Silk@nrc.gov. Determinations on requests for reasonable accommodation will be made on a case-by-case basis. STATUS: Public. Members of the public may request to receive the information in these notices TIME AND DATE: E:\FR\FM\25NON1.SGM 25NON1 Federal Register / Vol. 89, No. 227 / Monday, November 25, 2024 / Notices electronically. If you would like to be added to the distribution, please contact the Nuclear Regulatory Commission, Office of the Secretary, Washington, DC 20555, at 301–415–1969, or by email at Betty.Thweatt@nrc.gov or Samantha.Miklaszewski@nrc.gov. MATTERS TO BE CONSIDERED: Week of November 25, 2024 There are no meetings scheduled for the week of November 25, 2024. Week of December 2, 2024—Tentative Thursday, December 5, 2024 10:00 a.m. Briefing on Equal Employment Opportunity, Affirmative Employment, and Small Business (Public Meeting) (Contact: Erin Deeds: 301–415–2887) Additional Information: The meeting will be held in the Commissioners’ Hearing Room, 11555 Rockville Pike, Rockville, Maryland. The public is invited to attend the Commission’s meeting in person or watch live via webcast at the web address—https:// video.nrc.gov/. Week of December 9, 2024—Tentative There are no meetings scheduled for the week of December 9, 2024. Week of December 16, 2024—Tentative There are no meetings scheduled for the week of December 16, 2024. Week of December 23, 2024—Tentative There are no meetings scheduled for the week of December 23, 2024. Week of December 30, 2024—Tentative There are no meetings scheduled for the week of December 30, 2024. CONTACT PERSON FOR MORE INFORMATION: khammond on DSK9W7S144PROD with NOTICES For more information or to verify the status of meetings, contact Wesley Held at 301–287–3591 or via email at Wesley.Held@nrc.gov. The NRC is holding the meetings under the authority of the Government in the Sunshine Act, 5 U.S.C. 552b. Dated: November 20, 2024. For the Nuclear Regulatory Commission. Wesley W. Held, Policy Coordinator, Office of the Secretary. [FR Doc. 2024–27623 Filed 11–21–24; 11:15 am] BILLING CODE 7590–01–P VerDate Sep<11>2014 18:29 Nov 22, 2024 Jkt 265001 OFFICE OF PERSONNEL MANAGEMENT Submission for Review 3206–0261: Questionnaire for Non-Sensitive Positions (SF 85) Office of Personnel Management. ACTION: 30-Day notice and request for comments. AGENCY: The Office of Personnel Management (OPM) is requesting the Office of Management and Budget (OMB) renew a previously approved information collection, Questionnaire for Non-Sensitive Positions (SF 85). DATES: Comments are encouraged and will be accepted until December 26, 2024. SUMMARY: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to https://www.reginfo.gov/public/ do/PRAMain. Find this particular information collection request by selecting ‘‘Office of Personnel Management’’ under ‘‘Currently Under Review,’’ then check ‘‘Only Show ICR for Public Comment’’ checkbox. FOR FURTHER INFORMATION CONTACT: A copy of this ICR, with applicable supporting documentation, may be obtained by email to SuitEAforms@ opm.gov, or by contacting Lynnette Hornung 202–599–0090, or U.S. Office of Personnel Management, Suitability Executive Agent Programs, P.O. Box 699, Slippery Rock, PA 16057. SUPPLEMENTARY INFORMATION: This notice announces that OPM has submitted to OMB a request for renewal of a previously approved information collection, control number 3206–0261, Questionnaire for Non-Sensitive Positions (SF 85). The public has an additional 30-day opportunity to comment. The 60 day Federal Register Notice was published on September 11, 2024 (89 FR 73730). No comments were received. As required by the Paperwork Reduction Act of 1995, 44 U.S.C. 3506(c)(2), OPM is soliciting comments for this collection. The Office of Management and Budget is particularly interested in comment addressing the following issues: (1) whether this collection is necessary to the proper functions of OPM; (2) whether this information will be processed and used in a timely manner; (3) the accuracy of the burden estimates; (4) ways in which OPM might enhance the quality, utility, and clarity of the information to be collected; and (5) ways in which OPM ADDRESSES: PO 00000 Frm 00094 Fmt 4703 Sfmt 4703 92977 might minimize the burden of this collection on the respondents, including through the use of information technology. Background The Questionnaire for Non-Sensitive Positions, Standard Form 85 (SF 85) is an information collection completed by applicants for, or incumbents of, Federal Government civilian positions, or positions in private entities performing work for the Federal Government under contract. The collection is used as the basis of information for background investigations to establish that such individuals are: • Suitable for employment or retention in Federal employment in a low risk, non-sensitive position, or fit for employment or retention in Federal employment in the excepted service when the duties to be performed are equivalent to a low risk, non-sensitive position; • Fit to perform work on behalf of the Federal Government pursuant to the Government contract, when the duties to be performed are equivalent to a low risk, non-sensitive position; • Eligible for physical and logical access to federally controlled facilities or information systems, when the duties to be performed by the individual are equivalent to the duties performed by an employee in a low risk, non-sensitive position. For applicants, the SF 85 is used only after a conditional offer of employment has been made. eApplication (eApp) is a web-based system application that houses the SF 85. A variable in assessing burden hours is the nature of the electronic application. The electronic application includes branching questions and instructions which provide for a tailored collection from the respondent based on varying factors in the respondent’s personal history. The burden on the respondent is reduced when their personal history is not relevant to particular questions, since the question only branches or expands for additional details for those individuals who have pertinent information to provide regarding that line of questioning. Accordingly, the burden on the respondent will vary depending on whether the information collection relates to the respondent’s personal history. OPM requests renewal of the information collection for the SF 85. As we await the implementation of the Personnel Vetting Questionnaire, which was approved by the Office of Management and Budget (87 FR 71700 and 88 FR 12703) on November 15, 2023, agencies continue to use the SF 85 E:\FR\FM\25NON1.SGM 25NON1

Agencies

[Federal Register Volume 89, Number 227 (Monday, November 25, 2024)]
[Notices]
[Pages 92976-92977]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-27623]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2024-0001]


Sunshine Act Meetings

TIME AND DATE: Weeks of November 25 and December 2, 9, 16, 23, 30, 
2024. The schedule for Commission meetings is subject to change on 
short notice. The NRC Commission Meeting Schedule can be found on the 
internet at: https://www.nrc.gov/public-involve/public-meetings/schedule.html.

PLACE: The NRC provides reasonable accommodation to individuals with 
disabilities where appropriate. If you need a reasonable accommodation 
to participate in these public meetings or need this meeting notice or 
the transcript or other information from the public meetings in another 
format (e.g., braille, large print), please notify Anne Silk, NRC 
Disability Program Specialist, at 301-287-0745, by videophone at 240-
428-3217, or by email at [email protected]. Determinations on requests 
for reasonable accommodation will be made on a case-by-case basis.

STATUS: Public.
    Members of the public may request to receive the information in 
these notices

[[Page 92977]]

electronically. If you would like to be added to the distribution, 
please contact the Nuclear Regulatory Commission, Office of the 
Secretary, Washington, DC 20555, at 301-415-1969, or by email at 
[email protected] or [email protected].

MATTERS TO BE CONSIDERED: 

Week of November 25, 2024

    There are no meetings scheduled for the week of November 25, 2024.

Week of December 2, 2024--Tentative

Thursday, December 5, 2024
10:00 a.m. Briefing on Equal Employment Opportunity, Affirmative 
Employment, and Small Business (Public Meeting) (Contact: Erin Deeds: 
301-415-2887)

    Additional Information: The meeting will be held in the 
Commissioners' Hearing Room, 11555 Rockville Pike, Rockville, Maryland. 
The public is invited to attend the Commission's meeting in person or 
watch live via webcast at the web address--https://video.nrc.gov/.

Week of December 9, 2024--Tentative

    There are no meetings scheduled for the week of December 9, 2024.

Week of December 16, 2024--Tentative

    There are no meetings scheduled for the week of December 16, 2024.

Week of December 23, 2024--Tentative

    There are no meetings scheduled for the week of December 23, 2024.

Week of December 30, 2024--Tentative

    There are no meetings scheduled for the week of December 30, 2024.

CONTACT PERSON FOR MORE INFORMATION: For more information or to verify 
the status of meetings, contact Wesley Held at 301-287-3591 or via 
email at [email protected].
    The NRC is holding the meetings under the authority of the 
Government in the Sunshine Act, 5 U.S.C. 552b.

    Dated: November 20, 2024.

    For the Nuclear Regulatory Commission.
Wesley W. Held,
Policy Coordinator, Office of the Secretary.
[FR Doc. 2024-27623 Filed 11-21-24; 11:15 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.